Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Chronic neuropathic pain (CNP) is a disabling medical condition that impairs the health-related quality-of-life of affected patients. A high prevalence of anxiety, depression, sleep disturbance and cognitive impairment has frequently been reported in association with CNP, making the management of th...
Main Authors: | Daniela Adamo, Elena Calabria, Noemi Coppola, Giuseppe Pecoraro, Michele Davide Mignogna |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/20451253211034320 |
Similar Items
-
When orofacial pain needs a heart repair
by: Daniela Adamo, et al.
Published: (2021-04-01) -
Efficacy of vortioxetine monotherapy compared with combined therapy vortioxetine and olanzapine in the treatment of major depression – first results
by: Oppa M., et al.
Published: (2017-09-01) -
Sleep Disorders and Psychological Profile in Oral Cancer Survivors: A Case-Control Clinical Study
by: Roberta Gasparro, et al.
Published: (2021-04-01) -
Cannabis for chronic neuropathic pain
by: Eduardo Cuestas
Published: (2019-03-01) -
Neurosurgery for Chronic Neuropathic Pain
by: Jung Y Park, et al.
Published: (2000-01-01)